Anzeige
Mehr »
Login
Mittwoch, 14.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Extra! All-Time-High gesprengt - Strong Buy!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DLB7 ISIN: CA88337V1004 Ticker-Symbol: TTX 
Tradegate
13.04.21
16:37 Uhr
0,192 Euro
+0,006
+3,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERALASE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
THERALASE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1640,20209:33
0,1670,19309:30

Aktuelle News zur THERALASE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTheralase Technologies Inc: Theralase, PHAC to research Canadian COVID-19 vaccine-
THERALASE Aktie jetzt für 0€ handeln
FrTheralase inks collaborative research agreement for COVID-19 vaccine development-
FrTheralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine260TORONTO, ON / ACCESSWIRE / April 9, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
29.03.Theralase Technologies Inc.: Theralase Launches Anti-Cancer Therapy Research Centre210TORONTO, ON / ACCESSWIRE / March 29, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
25.03.Theralase Technologies Inc: Theralase adds sixth U.S. site for phase II study-
25.03.Theralase Technologies Inc.: Theralase Launches Sixth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study466TORONTO, ON / ACCESSWIRE / March 25, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
24.02.Theralase Technologies Inc: Theralase's fifth clinical site receives IRB approval2
24.02.Theralase Technologies Inc.: Theralase Launches Fifth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study1.025TORONTO, ON / ACCESSWIRE / February 24, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...
► Artikel lesen
01.02.Theralase Technologies Inc.: Theralase(R) Releases Quarterly Newsletter961TORONTO, ON / ACCESSWIRE / February 1, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and...
► Artikel lesen
27.01.Theralase Technologies Inc: Theralase receives IRB nod for fourth clinical site3
27.01.Theralase Technologies Inc.: Theralase Launches Fourth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study934TORONTO, ON / ACCESSWIRE / January 27, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...
► Artikel lesen
25.01.Theralase Technologies Inc: Theralase's third clinical site receives IRB approval3
25.01.Theralase Technologies Inc.: Theralase Launches Third Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study940TORONTO, ON / ACCESSWIRE / January 25, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...
► Artikel lesen
22.01.Theralase Technologies Inc: Theralase to receive Russian, Indian, Chinese patents2
22.01.Theralase Technologies Inc.: Theralase Expands Intellectual Property Portfolio1.103TORONTO, ON / ACCESSWIRE / January 22, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...
► Artikel lesen
20.01.Theralase Technologies Inc.: Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study1.126TORONTO, ON / ACCESSWIRE / January 20, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
19.01.Theralase Technologies Inc: Theralase receives OK for study at Virginia Urology2
19.01.Theralase Technologies Inc.: Theralase Launches First Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study887TORONTO, ON / ACCESSWIRE / January 19, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
09.01.Theralase Technologies Inc: Theralase to extend 4.09M warrants by two years4
09.01.Theralase Technologies Inc.: Theralase Announces Warrant Extension1.411TORONTO, ON / ACCESSWIRE / January 8, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development...
► Artikel lesen
Seite:  Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1